A major question in modern resuscitation medicine is whether the brain can be protected more effectively by keeping cardiac arrest survivors cold for longer. New findings reported in JAMA suggest that, among comatose adults who survived an out-of-hospital cardiac arrest and were treated with therapeutic hypothermia at 33 °C, extending the duration of cooling did not lead to better neurological outcomes. The result challenges the assumption that a longer period of temperature control necessarily provides additional protection against brain injury.
Cardiac arrest deprives the brain of oxygen and glucose within seconds, triggering a cascade of cellular damage that can continue even after circulation is restored. When blood flow returns, the sudden reintroduction of oxygen may generate harmful molecules, promote inflammation, disrupt the blood-brain barrier, and damage mitochondria, the structures responsible for producing cellular energy. Because lower body temperature reduces metabolic demand and may slow several of these processes, targeted temperature management has become an important component of post-cardiac-arrest care.
Therapeutic hypothermia at 33 °C is designed to reduce the brain’s energy requirements during the vulnerable period after resuscitation. Cooling is typically achieved with surface devices, intravascular systems, or a combination of methods, while patients are monitored closely for complications such as abnormal heart rhythms, electrolyte disturbances, infection, and impaired blood clotting. The treatment is particularly relevant for patients who remain comatose after circulation has been restored, because they cannot reliably regulate their own temperature or communicate symptoms.
The new study focused on whether the length of time spent at 33 °C changes the likelihood of meaningful recovery. Although the supplied study information does not provide the full numerical results, its central conclusion is clear: increasing cooling duration did not improve neurological outcomes in this population. That finding indicates that the biological benefits of hypothermia may reach a plateau, after which additional hours at the same temperature offer little or no measurable advantage.
Neurological recovery after cardiac arrest is influenced by many variables, including the initial heart rhythm, the time required to restore circulation, the quality of cardiopulmonary resuscitation, the cause of the arrest, blood pressure management, seizures, and complications affecting other organs. Temperature management is therefore only one part of a broader treatment strategy. Patients may also require mechanical ventilation, careful control of oxygen and carbon dioxide levels, treatment of seizures, hemodynamic support, and repeated neurological assessments over several days.
The study’s message is not that temperature management should be abandoned. Rather, it suggests that clinicians should be cautious about assuming that longer cooling is automatically better. Prolonged hypothermia can create practical and physiological burdens, including shivering, which raises metabolic demand; sedation and neuromuscular blockade, which can complicate neurological evaluation; slow drug metabolism; infection risk; and disturbances in potassium, magnesium, and glucose levels. If extended cooling does not improve outcomes, avoiding unnecessary treatment exposure could simplify care and reduce potential harm.
The findings also highlight the complexity of predicting recovery after cardiac arrest. Early examinations can be misleading because sedatives, paralytic medications, residual metabolic abnormalities, and the effects of low temperature may suppress reflexes and responses. Modern prognostication generally relies on a multimodal approach that may include serial clinical examinations, electroencephalography, brain imaging, and laboratory or neurophysiological tests. Decisions about long-term care should not be based on a single early sign.
For families, the research may be difficult to interpret because neurological outcome is not equivalent to survival alone. A patient can survive the initial arrest but remain severely disabled, while another may regain consciousness and recover substantial independence after a prolonged period of intensive care. The study addresses the influence of cooling duration within a highly specific group—comatose survivors of out-of-hospital cardiac arrest treated at 33 °C—and does not establish that every patient should receive the same temperature, duration, or post-resuscitation protocol.
The work comes from the Strategies to Innovate Emergency Care Clinical Trials Network, with Robert Silbergleit, MD, of the University of Michigan serving as the corresponding author. Its results are expected to contribute to continuing debates over the optimal temperature, timing, and duration of targeted temperature management. As resuscitation systems improve and more people survive cardiac arrest, determining which intensive-care treatments genuinely improve brain function—and which merely prolong complex therapy—will remain central to emergency and critical-care medicine.
Subject of Research: Neurological outcomes and the duration of therapeutic hypothermia in comatose survivors of out-of-hospital cardiac arrest.
Web References: https://doi.org/10.1001/jama.2026.10247
References: Silbergleit R, et al. JAMA. DOI: 10.1001/jama.2026.10247.
Keywords: cardiac arrest, out-of-hospital cardiac arrest, therapeutic hypothermia, targeted temperature management, 33 °C, coma, neurological outcomes, brain injury, resuscitation, critical care.
